Recurrence after surgery for clear cell and papillary renal cell carcinoma: Head-to head comparison of validated risk scores
- 29 January 2025
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 43 (7) , 443.e21-443.e28
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma PatientsEuropean Urology Focus, 2023
- Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell CancerClinical Genitourinary Cancer, 2023
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateEuropean Urology, 2022
- Tumor Stage and Substage Predict Cancer-specific Mortality After Nephrectomy for Nonmetastatic Renal Cancer: Histological Subtype-specific ValidationEuropean Urology Focus, 2022
- Risk Based Surveillance after Surgical Treatment of Renal Cell CarcinomaJournal of Urology, 2018
- Predicting Oncologic Outcomes in Renal Cell Carcinoma After SurgeryEuropean Urology, 2018
- Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-AnalysisJournal of Urology, 2016
- Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal CancerEuropean Urology, 2012
- External Validation of the Leibovich Prognosis Score for Nonmetastatic Clear Cell Renal Cell Carcinoma at a Single European Center Applying Routine PathologyJournal of Urology, 2011
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003